PPP1R1B and Huntington disease: In the current results, Lira further pinned down its capacity to improve behavioral functions by upregulating the gene expression of DARPP-32, which affects striatal function and plasticity as documented in Parkinson’s disease and schizophrenia (Meyer-Lindenberg et al., 2007), as well as models of HD.